The immune response in autism: a new frontier for autism research
The DOI matches its Crossref record; 202 of the 202 references it cites were found in a registry or an index.
Abstract
Autism spectrum disorders (ASD) are part of a broad spectrum of neurodevelopmental disorders known as pervasive developmental disorders, which occur in childhood. They are characterized by impairments in social interaction, verbal and nonverbal communication and the presence of restricted and repetitive stereotyped behaviors. At the present time, the etiology of ASD is largely unknown, but genetic, environmental, immunological, and neurological factors are thought to play a role in the development of ASD. Recently, increasing research has focused on the connections between the immune system and the nervous system, including its possible role in the development of ASD. These neuroimmune interactions begin early during embryogenesis and persist throughout an individual’s lifetime, with successful neurodevelopment contingent upon a normal balanced immune response. Immune aberrations consistent with a dysregulated immune response, which so far, have been reported in autistic children, include abnormal or skewed T helper cell type 1 (TH1)/TH2 cytokine profiles, decreased lymphocyte numbers, decreased T cell mitogen response, and the imbalance of serum immunoglobulin levels. In addition, autism has been linked with autoimmunity and an association with immune-based genes including human leukocyte antigen (HLA)-DRB1 and complement C4 alleles described. There is potential that such aberrant immune activity during vulnerable and critical periods of neurodevelopment could participate in the generation of neurological dysfunction characteristic of ASD. This review will examine the status of the research linking the immune response with ASD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is substantial evidence that the immune response alters the development of the CNS during fetal life8, 9”
From Elevated maternal C-reactive protein and autism in a national birth cohort (2014) · cites this paper as [9]
In the citing paper
“Numerous immune irregularities have been reported in children with ASD (Ashwood et al., 2011a; Ashwood et al., 2011b; Ashwood et al., 2006), especially with inflammatory cytokines.”
From Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders (2015) · cites this paper as Ashwood et al., 2006
In the citing paper
“Specifically, there is an association between ASD and maternal infection requiring hospitalization during pregnancy, elevated C-reactive protein, and a family history of autoimmune diseases.”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [78]
In the citing paper
“Prior literature has substantiated that infections during pregnancy have been correlated with increased frequency of neurodevelopmental disorders in offspring [16, 17, 76–78].”
From Gut microbiota changes in children with autism spectrum disorder: a systematic review (2020) · cites this paper as [78]
Citations
Cites
2 retracted
Wakefield, A., Murch, S., Anthony, A., Linnell, J., Casson, D., Malik, M., Berelowitz, M., Dhillon, A., Thomson, M., Harvey, P., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11096-0 · Cited by 3,006
RetractedEnterocolitis in children with developmental disorders
Wakefield, A. J., Anthony, A., MURCH, S. H., Thomson, M. A., Montgomery, S., Davies, S. E., O’Leary, J. J., Berelowitz, M., & Walker-Smith, J. A. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02041-4 · Cited by 246 · cited 1×
“mation and eosinophil infiltration [118–120].”
RetractedDiagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Rice, D., & Barone, S. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s3511 · Cited by 2,944 · cited 1×
“There are multiple, critical timepoints in neurodevelopment, including proliferation, migration, differentiation, synaptogenesis, gliogenesis, myelination, and apoptosis of neurons [14].”
BackgroundMendelson, G. (1995) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679509064964 · Cited by 2,858
Autism as a strongly genetic disorder: evidence from a British twin study
Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., & Rutter, M. (1995) · Psychological Medicine · doi:10.1017/s0033291700028099 · Cited by 2,461 · cited 1×
“children with ASD is estimated between 2% and 6% [8].”
BackgroundNeuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 1×
“[67] investigated the presence of immune activation in postmortem brain specimens and CSF from subjects with autism.”
BackgroundUnusual brain growth patterns in early life in patients with autistic disorder: An MRI study
Courchesne, E., Karns, C. M., Davis, H. R., Ziccardi, R., Carper, R. A., Tigue, Z. D., Chisum, H. J., Moses, P., Pierce, K., Lord, C., et al. (2001) · Neurology · doi:10.1212/wnl.57.2.245 · Cited by 1,487
Social amnesia in mice lacking the oxytocin gene
Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., & Winslow, J. T. (2000) · Nature Genetics · doi:10.1038/77040 · Cited by 1,130 · cited 1×
“Furthermore, oxytocin knockout mice have normal, cognitive abilities but diminished social recognition, suggesting a key role of oxytocin in social interactions [96].”
BackgroundHofman, A., Ott, A., Breteler, M. M., Bots, M. L., Slooter, A. J., van Harskamp, F., van Duijn, C. N., Van Broeckhoven, C., & Grobbee, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09328-2 · Cited by 1,062 · cited 1×
“Vascular changes related with aging (artherosclerosis, hypertension) are risk factors for AD [194, 195].”
Background
Research works printed but not linked: 7
- Cook, 1998, Genetics of autism, Ment. Retard. Dev. Disabil. Res. Rev., 4, 113, 10.1002/(SICI)1098-2779(1998)4:2<113::AID-MRDD8>3.0.CO;2-Q · DOI · Paper page
- Villalobos, 1996, Prolonged EEG monitoring findings in children with pervasive developmental disorder and regression, Ann. Neurol., 40, 300
- Licinio, 1998, Cytokines and brain function: relevance to interferon-α-induced mood and cognitive changes, Semin. Oncol., 25, 30
- Chugani, 1999, Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children, Ann. Neurol., 45, 287, 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9 · doi:10.1002/1531-8249(199903)45:3<287::aid-ana3>3.0.co;2-9
- Rumsey, 2000, Functional neuroimaging of autistic disorders, Ment. Retard. Dev. Disabil. Res. Rev., 6, 171, 10.1002/1098-2779(2000)6:3<171::AID-MRDD4>3.0.CO;2-N · doi:10.1002/1098-2779(2000)6:3<171::aid-mrdd4>3.0.co;2-n
- Ashwood, 2003, Intestinal lymphoctye populations in children with regressive autism: evidence for extensive mucosal immunopathology, J. Clin. Immunol., 23, 504, 10.1023/B:JOCI.0000010427.05143.bb · DOI · Paper page
- Knivsberg, 2002, A randomized, controlled study of dietary intervention in autistic syndromes, Nutr. Neurosci., 5, 251, 10.1080/10284150290028945 · DOI · Paper page
Cited by
Items 201–300 of 527
Dioxins as potential risk factors for autism spectrum disorder
Guo, Z., Xie, H. Q., Zhang, P., Luo, Y., Xu, T., Liu, Y., Fu, H., Xu, S. L., Valsami‐Jones, E., Boksa, P., et al. (2018) · Environment International · doi:10.1016/j.envint.2018.10.028 · Cited by 46
Demeestere, D., Libert, C., & Vandenbroucke, R. E. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.06.010 · Cited by 43
“Peripheral inflammation and neuroinflammation are both present in autism since autistic individuals have elevated levels of pro-inflammatory cytokines and chemokines in the serum and CSF (Ashwood et al., 2006; Ashwood and Van de Water, 2004).”
BackgroundBasic Concept of Microglia Biology and Neuroinflammation in Relation to Psychiatry
Mattei, D., & Notter, T. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_83 · Cited by 39
Sun, L., Yi, S., & O’Connell, P. J. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2009.117 · Cited by 37
Wu, J., Yi, S., Ouyang, L., Jimenez, E., Simond, D. M., Wang, W., Wang, Y., Hawthorne, W. J., & O’Connell, P. J. (2008) · Transplantation · doi:10.1097/tp.0b013e3181734793 · Cited by 36
Windham, G. C., Lyall, K., Anderson, M., & Kharrazi, M. (2016) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-015-2587-2 · Cited by 36
“Evidence suggests a role for AFP in regulation of estrogen concentrations (as a binding protein), as well as in impairing dendritic cells and inducing immune dysfunction (Mizejewski 2007), thereby providing a linkage to autism (Ashwood et al. 2006; Gesundheit et al. 2013; Goines and Van de Water 2010).”
BackgroundArteaga-Henríquez, G., Gisbert, L., & Ramos‐Quiroga, J. A. (2023) · CNS Drugs · doi:10.1007/s40263-023-00993-x · Cited by 43
“Individuals with ASD often display abnormal immune responses [10, 11], and are also characterized by a higher incidence of comorbid immune-mediated conditions, such as diabetes mellitus [12], psoriasis [13], autoimmune thyroiditis [14], and/or allergy [15].”
BackgroundMicroglia-derived neuregulin expression in psychiatric disorders
Ikawa, D., Makinodan, M., Iwata, K., Ohgidani, M., Kato, T. A., Yamashita, Y., Yamamuro, K., Kimoto, S., Toritsuka, M., Yamauchi, T., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.01.003 · Cited by 44
“Such studies have reported abnormal cytokine profiles, reduced lymphocyte numbers, weakened T-cell mitogen responses, imbalanced serum immunoglobulin levels, and aberrant autoimmune-related gene expression in these patients (Ashwood et al., 2006; Estes and McAllister, 2015; Hughes et al., 2016; Muller et al., 2015; On…”
BackgroundAssociation between PTGS2 polymorphism and autism spectrum disorders in Korean trios
Yoo, H. J., Cho, I. H., Park, M., Cho, E., Cho, S. C., Kim, B.-N., Kim, J., & Kim, S. A. (2008) · Neuroscience Research · doi:10.1016/j.neures.2008.05.008 · Cited by 42
Prandota, J. (2010) · Research in Autism · doi:10.1016/j.rasd.2010.03.009 · Cited by 35
High Complement Factor I Activity in the Plasma of Children with Autism Spectrum Disorders
Momeni, N., Brudin, L. H., Behnia, F., Nordström, B. M., Yosefi-Oudarji, A., Sivberg, B. V., Joghataei, M. T., & Persson, B. L. (2011) · Autism Research and Treatment · doi:10.1155/2012/868576 · Cited by 37
“Protein products of immune activation, such as cytokines, can be linked to core features of ASD, such as difficulties to regulate affect, sleep, nutritional uptake, and can also affect behaviour and social communication [39].”
BackgroundA Search for Blood Biomarkers for Autism: Peptoids
Zaman, S., Yazdani, U., Deng, Y., Li, W., Gadad, B. S., Hynan, L., Karp, D., Roatch, N., Schutte, C., Nathan Marti, C., et al. (2016) · Scientific Reports · doi:10.1038/srep19164 · Cited by 33
Sbacchi, S., Acquadro, F., Calo, I., Calì, F., & Romano, V. (2010) · Current Genomics · doi:10.2174/138920210790886880 · Cited by 35
“ASD = Autism Spectrum Disorders CGH = Comparative Genomic Hybridization CNV = Copy Number Variant DAVID = Database for Annotation, Visualization and Integrated Discovery FDR = False Discovery Rate GO = Gene Ontology IPA = Ingenuity Pathway Analysis”
BackgroundB and T Immunoregulation: A New Insight of B Regulatory Lymphocytes in Autism Spectrum Disorder
GIACOMO, A. D., Gargano, C. D., Simone, M., Petruzzelli, M. G., Pedaci, C., Giambersio, D., Margari, L., & Ruggieri, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.732611 · Cited by 48
Curtis, J. T., Chen, Y., Buck, D. J., & Davis, R. L. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.08.053 · Cited by 35
Gonzalez–Gronow, M., Cuchacovich, M., Francos, R., Cuchacovich, S., Fernández, M. D. P., Blanco, A., Bowers, E. V., Kaczowka, S. J., & Pizzo, S. V. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.06.001 · Cited by 32
“These patients show decreased peripheral lymphocyte numbers, decreased responses to T cell mitogens, dysregulated apoptotic mechanisms, imbalance of serum immunoglobulin levels, and the presence of serumautoantibodies directedagainst components of the central nervous system (Ashwood et al., 2006).”
BackgroundInfluentialSmith, S. C., & Wagner, M. (2014) · PubMed · Cited by 48
Ahmad, S. F., Ansari, M. A., Nadeem, A., Bakheet, S. A., AL-Ayadhi, L. Y., & Attia, S. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.10.001 · Cited by 33
“Immune alterations related to immune dysregulation in AU include abnormal cytokine and lymphocyte profiles (Ashwood et al., 2006).”
BackgroundInfluentialKarlsson, H., Sjöqvist, H., Brynge, M., Gardner, R. M., & Dalman, C. (2022) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-022-09422-4 · Cited by 41
High plasma neopterin levels in Chinese children with autism spectrum disorders
Zhao, H., Yin, S.-S., & Fan, J. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.02.002 · Cited by 35
“…neural dysfunction in autism and that the cerebellum is the focus of an active and chronic neuroinflammatory process in autistic patients, while Ashwood et al. (2006) reported that immune activity during vulnerable and critical periods of neurodevelopment could participate in the generation of…”
BackgroundTrajkovski, V., Петличковски, А., Ефинска-Младеновска, О., Трајков, Д., Arsov, T., Strezova, A., Ajdinski, L., & Spiroski, M. Z. (2008) · Focus on Autism and Other Developmental Disabilities · doi:10.1177/1088357608320413 · Cited by 37
“There is potential that such aberrant immune activity during vulnerable and critical periods of neurodevelopment could participate in the generation of neurological dysfunction characteristic of autistic disorder (Ashwood et al., 2006).”
BackgroundCritical Role of the Maternal Immune System in the Pathogenesis of Autism Spectrum Disorder
Ravaccia, D., & Ghafourian, T. (2020) · Biomedicines · doi:10.3390/biomedicines8120557 · Cited by 41
“Some of the strongest evidence in support of the role of maternal infections in the aetiology of ASD comes from the maternal immune activation (MIA) of mouse model, which assesses how maternal infection and/or consequent immune activation leads to aberrant neurodevelopmental and behavioural phenotypes in the new-born…”
BackgroundIn Utero Environmental Tobacco Smoke Exposure Alters Gene Expression in Lungs of Adult BALB/c Mice
Rouse, R. L., Boudreaux, M. J., & Penn, A. L. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10358 · Cited by 37
“Recent findings implicate in utero environmental exposures in developmental disorders such as autism (Ashwood et al. 2006).”
BackgroundChange in Plasma Cytokine Levels During Risperidone Treatment in Children with Autism
Choi, J. E., Widjaja, F., Careaga, M., Bent, S., Ashwood, P., & Hendren, R. L. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0108 · Cited by 31
“Their results are consistent with data from other studies that showed an increase in protein levels of MCP-1 and eotaxin in brain specimens from individuals with ASD (Vargas et al. 2005) or for pro-inflammatory cytokines in the blood of ASD children (Ashwood et al. 2011a).”
InfluentialSelf-citationMorris, G., Puri, B. K., Frye, R. E., & Maes, M. H. J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0692-2 · Cited by 33
Cui, Y., Li, Q., Yang, D., & Yang, Y. (2024) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2024.124100 · Cited by 30
Chonchaiya, W., Tassone, F., Ashwood, P., Hessl, D., Schneider, A., Campos, L., Nguyen, D. V., & Hagerman, R. J. (2010) · Human Genetics · doi:10.1007/s00439-010-0882-8 · Cited by 30
“proposed to play a role in at least a subgroup of children with ASD (Ashwood et al. 2006; Enstrom et al. 2009).”
BackgroundSelf-citationGonzalez–Gronow, M., Cuchacovich, M., Francos, R., Cuchacovich, S., Blanco, A., Sandoval, R., Gomez, C. F., Valenzuela, J. A., Ray, R., & Pizzo, S. V. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.07.006 · Cited by 29
“Autoantibodies to MBP have been detected in ASD (Ashwood et al., 2006) and in MS (Weber et al., 2011).”
Decreased levels of serum fibroblast growth factor-2 in children with autism spectrum disorder
Esnafoğlu, E., & Ayyıldız, S. N. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.07.028 · Cited by 34
“ASD is an idiopathic multifactorial neurodevelopmental disorder (Ashwood et al., 2006; Lai, Lombardo and Baron-Cohen, 2014).”
BackgroundDietert, R. R., & Dietert, J. M. (2008) · Toxicology · doi:10.1016/j.tox.2008.01.022 · Cited by 33
The human cathelicidin, LL-37, induces granzyme-mediated apoptosis in cytotoxic T lymphocytes
Mader, J. S., Marcet‐Palacios, M., Hancock, R. E. W., & Bleackley, R. C. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.11.015 · Cited by 29
Is Taurine a Biomarker in Autistic Spectrum Disorder?
Park, E., Cohen, I. L., Gonzalez, M. G., Castellano, M. R., Flory, M. J., Jenkins, E. C., Brown, W. T., & Schuller‐Levis, G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-1079-2_1 · Cited by 31
“TH1/TH2 dysregulation, an increase in CNS chemokines, increased NO, HLA association, increased microglial activation, and astrocytosis demonstrate the role of immunity in ASD (Vargas et al. 2005; Ashwood et al. 2006).”
BackgroundHeuer, L. S., Rose, M., Ashwood, P., & Van de Water, J. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.001 · Cited by 28
“…the presence of autoantibodies, altered cytokine profiles, immunepathology nt R829388. y, Allergy and Clinical Immualth Sciences Drive, Davis, CA 047. e Water). l rights reserved. in the gut, altered levels of complement proteins, and altered levels of immunoglobulins (Ashwood et al., 2006).”
BackgroundSelf-citationMeta-analysis of differentially expressed genes in autism based on gene expression data
Ning, L., Yu, Y., GuoJi, E. T., Kou, C., Wu, Y., Shi, J., Ai, L., & Yu, Q. (2015) · Genetics and Molecular Research · doi:10.4238/2015.march.27.1 · Cited by 30
“Various other factors have been implicated, including immunological (Ashwood et al., 2006), neurological (Hashimoto et al.”
BackgroundAlzghoul, L., Abdelhamid, S. S., Yanis, A., Qwaider, Y. Z., Aldahabi, M., & Albdour, S. (2019) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1812-167 · Cited by 32
“Cytokines can also modulate brain function, affecting cognitive and emotional processing, and might be responsible for the mood and sleep disturbances commonly seen in children with ASD [9].”
BackgroundNeonatal Levels of Acute Phase Proteins and Risk of Autism Spectrum Disorder
Gardner, R. M., Lee, B. K., Brynge, M., Sjöqvist, H., Dalman, C., & Karlsson, H. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.09.005 · Cited by 30
Allergies in Children with Autism Spectrum Disorder: a Systematic Review and Meta-analysis
Miyazaki, C., Koyama, M., Ota, E., Swa, T., Amiya, R. M., Mlunde, L. B., Tachibana, Y., Yamamoto‐Hanada, K., & Mori, R. (2015) · Review Journal of Autism and Developmental Disorders · doi:10.1007/s40489-015-0059-4 · Cited by 35
“Some studies have demonstrated that the imbalance between inflammatory mediators and their counterregulatory molecules could affect the central nervous system homeostasis, which can result in neurological disorders or possible ASD development in the affected child (Wei et al. 2011; Goyal and Miyan 2014; Ashwood et al.…”
BackgroundInfluentialIncreased Serum Levels of Epidermal Growth Factor in Children with Autism
İşeri, E., Güney, E., Ceylan, M. F., Yücel, A. A., Aral, A., Bodur, Ş., & Şener, Ş. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1046-3 · Cited by 28
“But various factors such as neurological, environmental, immunological and genetic factors play a role in etiopathogenesis of this disorder ( Ashwood et al. 2006; Chauhan and Chauhan 2006).”
BackgroundEnstrom, A. M., Onore, C. E., Tarver, A., Hertz‐Picciotto, I., Hansen, R. L., Croen, L., de Water, J. V., & Ashwood, P. (2008) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2008.121.129 · Cited by 32
“A large, growing body of research has revealed that immune responses can influence neurodevelopment and that significant alterations in the immune system may play a key role in some individuals with autism [ 13 ]”
BackgroundSelf-citationAutism Associated With Anti-NMDAR Encephalitis: Glutamate-Related Therapy
Tzang, R., Chang, C., Chang, Y., & Lane, H. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00440 · Cited by 31
“Such genes show aberrant immune activity during vulnerable and critical periods of neurodevelopment, participating in the generation of the neurological dysfunction characteristic of ASD (35).”
BackgroundA Novel and Reliable Rat Model of Autism
Qi, Z., Lyu, M., Yang, L., Yuan, H., Cao, Y., Zhai, L., Dang, W., Liu, J., Yang, F., & Li, Y. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.549810 · Cited by 30
“It has been reported that patients with ASD and their families have been diagnosed with immune abnormalities; however, the causal relationship between pregnant mothers’ immune status and the risk of having children with ASD is still unclear (22, 23).”
BackgroundOutdoor light at night and autism spectrum disorder in Shanghai, China: A matched case-control study
Xie, Y., Jin, Z., Huang, H., Li, S., Dong, G., Liu, Y., Chen, G., & Guo, Y. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.152340 · Cited by 31
Autism spectrum disorder: diagnosis and management
O'Hare, A. E. (2009) · Archives of Disease in Childhood Education & Practice · doi:10.1136/adc.2008.150490 · Cited by 30
“This is a vexatious issue as it is understandably of great interest and importance to affected families but it is an enormous literature and can be difficult to address in the context of busy clinical practice. This literature ranges from that in which the evidence is still evolving from early scientific enquiry, such…”
BackgroundTripathi, N. (2016) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000107 · Cited by 31
“Autism, and, more broadly, Autism Spectrum Disorder (ASD), is a condition characterized by impaired cognitive and social skills [1], along with a compromised immune function [2-5].”
BackgroundCharacterization of Immune Cell Phenotypes in Adults with Autism Spectrum Disorders
López-Cacho, J. M., Gallardo, S., de la Paz, M. P., Aguerri, M., Calzada, D., Mayayo, T., Lahoz, C., & Cárdaba, B. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000070 · Cited by 33
Bilbo, S. D., Nevison, C. D., & Parker, W. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.26253 · Cited by 26
Prilutsky, D., Kho, A. T., Palmer, N., Bhakar, A. L., Smedemark-Margulies, N., Kong, S. W., Margulies, D. M., Bear, M. F., & Kohane, I. S. (2015) · Molecular Autism · doi:10.1186/s13229-015-0061-9 · Cited by 27
“The immunological phenotype therefore adds to prior evidence of a link between CNS pathology and glial activation [46, 47] in Fmr1KO mice [41].”
BackgroundImproving the Prediction of Response to Therapy in Autism
Bent, S., & Hendren, R. L. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.011 · Cited by 25
IFNG/IFNG-AS1 expression level balance: implications for autism spectrum disorder
Fallah, H., Sayad, A., Ranjbaran, F., Talebian, F., Ghafouri‐Fard, S., & Taheri, M. N. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00510-4 · Cited by 26
[Association between HSV-2 infection and serum anti-rat brain antibodies in patients with autism].
Mora, M., Quintero, L., Cardenas, R., Suárez-Roca, H., Zavala, M. D. M., & Montiel, N. (2009) · PubMed · Cited by 27
Possible use of Trichuris suis ova in autism spectrum disorders therapy
Siniscalco, D., & Antonucci, N. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.03.024 · Cited by 25
“mune alterations include abnormal or skewed T helper cell type 1 Th1/Th2 cytokine profiles, decreased lymphocyte numbers and T cell mitogen response, imbalance in serum immunoglobulin levels [48,49].”
BackgroundIvanovska, M., Abdi, Z., Murdjeva, M., Macêdo, D. S., Maes, A., & Maes, M. H. J. (2020) · Preprints.org · doi:10.20944/preprints202001.0370.v1 · Cited by 24
The role of glycogen synthase kinase-3 signaling in neurodevelopment and fragile X syndrome.
Portis, S. M., Giunta, B. N., Obregon, D. F., & Tan, J. (2012) · Europe PMC (PubMed Central) · Cited by 38
Plasma level of transforming growth factor β 1 in children with autism spectrum disorder
Gohary, T. M. E., Aziz, N. A. E., Darweesh, M. E., & Sadaa, E. S. (2014) · Egyptian Journal of Ear Nose Throat and Allied Sciences · doi:10.1016/j.ejenta.2014.12.002 · Cited by 27
Brain Autoantibodies in Autism Spectrum Disorder
Elamin, N. E., & AL-Ayadhi, L. Y. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.14.1 · Cited by 26
Stafeev, I., Menshikov, M. Y., Цоколаева, З. И., Shestakova, M. V., & Parfyonova, Y. V. (2015) · Biochemistry (Moscow) · doi:10.1134/s0006297915100028 · Cited by 25
Autism spectrum disorders and natural killer cells: a review on pathogenesis and treatment
Meimand, S. E., Abadi, Y. R., & Rezaei, N. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1850273 · Cited by 27
Dewitt, J. J., Hecht, P. M., Grepo, N., Wilkinson, B., Evgrafov, O. V., Morris, K. V., Knowles, J. A., & Campbell, D. B. (2016) · Developmental Neuroscience · doi:10.1159/000453258 · Cited by 22
Expression of Reactive Oxygen Species–Related Transcripts in Egyptian Children With Autism
Meguid, N. A., Ghozlan, S. A. S., Mohamed, M. F., Ibrahim, M. K., Dawood, R. M., Din, N. G. B. E., Abdelhafez, T. H., Hemimi, M., & Awady, M. K. E. (2017) · Biomarker Insights · doi:10.1177/1177271917691035 · Cited by 25
Guo, Q., Yin, X., Qiao, M., Jia, Y., Chen, D., Shao, J., LeBaron, T. W., Gao, Y., Shi, H., & Jia, B. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00170 · Cited by 24
Simone, R. D., Butera, A., Armida, M., Pèzzola, A., Boirivant, M., Potenza, R. L., & Ricceri, L. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.03.041 · Cited by 23
Current Issues in Atopic Comorbidities and Preventing the Atopic March
Simpson, E. L., Eichenfield, L. F., Ellis, C. N., Mancini, A. J., & Paller, A. S. (2012) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2012.08.001 · Cited by 22
Guerra, D. J. (2011) · Autism Research and Treatment · doi:10.1155/2011/398636 · Cited by 28
“Alterations in this ratio were reported in ASD children [68].”
BackgroundResultImpaired Sulfate Metabolism and Epigenetics: Is There a Link in Autism?
Hartzell, S., & Seneff, S. (2012) · Entropy · doi:10.3390/e14101953 · Cited by 23
Ahmad, S. F., Ansari, M. A., Nadeem, A., Bakheet, S. A., AL-Ayadhi, L. Y., Alotaibi, M. R., Alhoshani, A., Alshammari, M. A., & Attia, S. M. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.12.020 · Cited by 25
Andersen, A. B., Ehrenstein, V., Erichsen, R., Frøslev, T., & Sørensen, H. T. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s59360 · Cited by 22
“2,3 The two diseases may share genetic loci, 4,5 whereas the rapid contemporaneous rise in the occurrence of IBD and ASD suggests that the two conditions may also share environmental risk factors.”
Bilbo, S. D., Jones, J. P., & Parker, W. (2012) · Autism Research and Treatment · doi:10.1155/2012/910946 · Cited by 21
“These include evidence of brain specific auto-antibodies, altered T, B, and NK cell responses to antigen, altered cytokine production, an increased incidence of allergies and other autoimmune disorders, and functional changes in brain glial cells (microglia and astrocytes) [4–11].”
Kohane, I. S. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.024 · Cited by 23
Brown, A. C., & Mehl‐Madrona, L. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.46 · Cited by 22
Autism and associated disorders: cannabis as a potential therapy
Babayeva, M., Assefa, H., Basu, P., & Loewy, Z. G. (2022) · Frontiers in Bioscience-Elite · doi:10.31083/j.fbe1401001 · Cited by 35
The Hepatic Mitochondrial Alterations Exacerbate Meta-Inflammation in Autism Spectrum Disorders
Trinchese, G., Cimmino, F., Cavaliere, G., Catapano, A., Fogliano, C., Lama, A., Pirozzi, C., Cristiano, C., Russo, R., Petrella, L., et al. (2022) · Antioxidants · doi:10.3390/antiox11101990 · Cited by 22
“In individuals with ASD, several lines of evidence point to ongoing inflammation in the brain [5] as well as in the peripheral tissues [4,6].”
BackgroundValayi, S., Eftekharian, M. M., Taheri, M. N., & Alikhani, M. Y. (2018) · Human Antibodies · doi:10.3233/hab-180335 · Cited by 21
“…[18] and also, the association between autism and immune-related genes include complement C4 alleles and human leukocyte antigen (HLA) [19] may cause neurological manifestations of ASD especially if they occurred during critical neurodevelopmental periods of pregnancy and early infancy [20].”
Ahmad, S. F., Bakheet, S. A., Ansari, M. A., Nadeem, A., Alobaidi, A. F., Attia, S. M., Alhamed, A. S., Aldossari, A. A., & Mahmoud, M. A. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.10.014 · Cited by 21
Fu, Y., Yi, S., Wu, J., Jimenez, E., Simond, D. M., Hawthorne, W. J., & O’Connell, P. J. (2008) · Transplantation · doi:10.1097/tp.0b013e31818530fd · Cited by 21
Hwang, S.-R., Kim, C., Shin, K.-M., Jo, J.-H., Kim, H., & Heo, Y. (2015) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2015.1010466 · Cited by 21
“Changes in mucosal immunity, which may be involved with gastrointestinal symptoms reported in approximately 20% of autistic children (Ashwood and Van de Water, 2004; Ashwood et al., 2006), were also found in adult BTBR mice compared with highly social FVB/NJ (FVB) mice.”
BackgroundEtiology of autism spectrum disorders: Genes, environment, or both?
Shaw, C., Sheth, S. K. S., Li, D., & Tomljenovic, L. (2014) · Cited by 24
López‐Aranda, M. F., Chattopadhyay, I., Boxx, G. M., Fraley, E., Silva, T. K., Zhou, M., Phan, M., Herrera, I., Taloma, S. E., Mandanas, R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf2073 · Cited by 21
Lipid Signalling in the Pathology of Autism Spectrum Disorders
Wong, C. T., & Crawford, D. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4788-7_68 · Cited by 31
“The activity and production of COX-2 are induced by cytokines and proinflammatory agents, and irregular immune responses have been characterized in patients with ASDs (Ashwood et al. 2006).”
BackgroundSex‐specific association of a common variant of the XG gene with autism spectrum disorders
Chang, S., Pauls, D. L., Lange, C., Sasanfar, R., & Santangelo, S. L. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32165 · Cited by 21
Dietert, R. R. (2008) · Current Drug Safety · doi:10.2174/157488608785699450 · Cited by 19
“A primary feature of autism-associated immune dysfunction is inflammatory dysregulation in combination with general immune activation [60-62].”
BackgroundGenome-Wide Changes in Protein Translation Efficiency Are Associated with Autism
Rogozin, I. B., Gertz, E. M., Baranov, P. V., Poliakov, E., & Schäffer, A. A. (2018) · Genome Biology and Evolution · doi:10.1093/gbe/evy146 · Cited by 29
Ahmad, S. F., Ansari, M. A., Nadeem, A., Bakheet, S. A., Alshammari, M. A., & Attia, S. M. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.08.020 · Cited by 20
Ahmad, S. F., Ansari, M. A., Nadeem, A., Bakheet, S. A., Mohammad, R., & Attia, S. M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0548-9 · Cited by 21
“cluding aberrant mucosal immunity, has been reported for autistic subjects [4].”
BackgroundAhmad, S. F., Nadeem, A., Ansari, M. A., Bakheet, S. A., Alasmari, F. F., Alasmari, A. F., Al‐Kharashi, L. A., Alqahtani, Q. H., & Attia, S. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116930 · Cited by 17
Makris, G., Chouliaras, G. L., Apostolakou, F., Papageorgiou, C., Chrousos, G. P., Papassotiriou, I., & Pervanidou, P. (2021) · Children · doi:10.3390/children8060478 · Cited by 20
“To date, the exact etiology and underlying neuropathology of ASD remain largely unknown, although it is likely to result from a complex combination of environmental, neurological, immunological, genetic, and epigenetic factors [2,3].”
BackgroundTrama, A. M., Holzknecht, Z. E., Thomas, A. D., Su, K., Lee, S. M., Foltz, E. E., Perkins, S. E., Lin, S. S., & Parker, W. (2012) · Cellular and Molecular Immunology · doi:10.1038/cmi.2011.61 · Cited by 20
Saxena, V., Ramdas, S., Ochoa, C. R., Wallace, D., Bhide, P., & Kohane, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048835 · Cited by 18
“Prior work as reviewed in [19] has implicated immune function in autism histologically in brain and blood, in the expression of proteins in brain and blood, and in several epidemiological studies.”
BackgroundVentura, G., Calvano, C. D., Porcelli, V., Palmieri, L., GIACOMO, A. D., Xu, Y., Goodacre, R., Palmisano, F., & Cataldi, T. R. I. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02817-z · Cited by 18
“Interestingly, several lines of evidence indicate that diverse genetic as well as environmental risk factors may converge on a smaller number of interacting molecular pathways, including Ca homeostasis [6, 7], mitochondrial function [8, 9], and immune response [10, 11], which in turn impact brain circuit development a…”
BackgroundHan, Y. M. Y., Chan, A. S.-Y., Sze, S. L., Cheung, M., Wong, C. K., Lam, J. M. K., & Poon, P. M. K. (2013) · Research in Autism · doi:10.1016/j.rasd.2013.02.011 · Cited by 20
The use of stem cells to study autism spectrum disorder.
Ardhanareeswaran, K., Coppola, G., & Vaccarino, F. M. (2015) · PubMed Central · Cited by 22
Autism: A Systems Biology Disease
Randolph-Gips, M. M. (2011) · IEEE International Conference on Healthcare Informatics, Imaging and Systems Biology · doi:10.1109/hisb.2011.13 · Cited by 20
“Anti-brain antibodies have been found in children with autism, though no evidence of demyelination has been found.[57] Children with Cerebral Folate Deficiency (CFD), have a high rate of autism.”
BackgroundAcetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder
Schultz, S. T., & Gould, G. G. (2016) · Autism - Open Access · doi:10.4172/2165-7890.1000170 · Cited by 23
“It has been shown in many studies that children with ASD have immune system dysregulation [37-43].”
BackgroundCerebrospinal fluid and serum protein markers in autism: A co‐twin study
Smedler, E., Kleppe, J., Neufeld, J., Remnélius, K. L., Bölte, S., & Landén, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15338 · Cited by 18
“Increasing evidence points at altered immune response in ASD (Ashwood et al., 2006).”
BackgroundAluminum as a CNS and Immune System Toxin Across the Life Span
Shaw, C. A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1370-7_4 · Cited by 19
Ahmad, S. F., Ansari, M. A., Nadeem, A., Bakheet, S. A., Alotaibi, M. R., Alasmari, A. F., Alshammari, M. A., Al‐Mazroua, H. A., & Attia, S. M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.01.016 · Cited by 17
DeSpenza, T., Kiziltug, E., Allington, G., Barson, D. G., McGee, S., O’Connor, D. A., Robert, S. M., Mekbib, K. Y., Nanda, P., Greenberg, A. B. W., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-024-01865-3 · Cited by 17
Altered cytokine levels in the cerebrospinal fluid of adult patients with autism spectrum disorder
Runge, K., Fiebich, B. L., Kuzior, H., Rausch, J., Maier, S. J., Dersch, R. S., Nickel, K., Domschke, K., van Elst, L. T., & Endres, D. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.12.032 · Cited by 21
Rosenspire, A. J., Yoo, W., Menard, S. L., & Torres, A. R. (2011) · Autism Research · doi:10.1002/aur.194 · Cited by 18
Measuring robustness of brain networks in autism spectrum disorder with Ricci curvature
Simhal, A. K., Carpenter, K. L. H., Nadeem, S., Kurtzberg, J., Song, A. W., Tannenbaum, A., Sapiro, G., & Dawson, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-67474-9 · Cited by 22
Network analysis of autistic disease comorbidities in Chinese children based on ICD-10 codes
Li, X., Liu, G., Chen, W.-X., Bi, Z., & Liang, H. (2020) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-020-01282-z · Cited by 20
Metadata
- Authors
- Ashwood, P., Wills, S., & Van de Water, J.
- Affiliations
- University of California, Davis (US)
- University of California Davis Medical Center (US)
- Division of Rheumatology, Allergy and Clinical Immunology, University of California Davis , Sacramento
- Corresponding author
- Ashwood, Paul
- ORCID
- Ashwood, Paul
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05-12
- Volume
- 80
- Issue
- 1
- Pages
- 1-15
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2167538265
- Cited by
- 528
- References
- 202
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 20 · 2023: 8 · 2022: 23 · 2021: 16 · 2020: 25 · 2019: 24 · 2018: 27 · 2017: 30 · 2016: 21 · 2015: 41 · 2014: 26 · 2013: 41 · 2012: 43
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Leukocyte Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- autism spectrum disorder, neuroimmune interactions, immune dysregulation, T-cell mitogen response, immunoglobulin levels, autoimmunity, HLA-DRB1, complement C4, brain development, autism etiology
- MeSH terms
- Animals, Autistic Disorder, Complement C4, T-Lymphocytes, Helper-Inducer, HLA-DR Antigens, Humans, Autoimmunity, HLA-DRB1 Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.